Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE·Healthcare·Biotechnology
$7.82
+0.00%
Mkt Cap $487.35M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $37.09M | $33.00M | -11.03% | -$1.80 | -$1.42 | +21.11% | — | — |
| Q4 2025 Nov 6, 2025 | $37.57M | $38.84M | +3.38% | -$1.24 | -$1.45 | -16.94% | — | — |
| Q3 2025 Aug 7, 2025 | $38.95M | $49.60M | +27.37% | -$1.44 | -$1.10 | +23.61% | — | — |
| Q2 2025 May 6, 2025 | $41.60M | $48.32M | +16.16% | -$1.23 | -$1.58 | -28.46% | — | — |
| Q1 2025 Feb 25, 2025 | $38.70M | $43.85M | +13.31% | -$1.45 | -$1.82 | -25.52% | — | — |
| Q4 2024 Nov 12, 2024 | $44.43M | $89.05M | +100.43% | -$2.40 | -$1.08 | +55.00% | — | — |
| Q3 2024 Aug 8, 2024 | $45.00M | $56.21M | +24.90% | -$3.20 | -$3.20 | +0.00% | — | — |
| Q2 2024 May 9, 2024 | $43.71M | $37.94M | -13.19% | -$3.20 | -$3.20 | +0.00% | — | — |
| Q1 2024 Feb 29, 2024 | $46.04M | $34.76M | -24.51% | -$3.60 | -$3.60 | +0.00% | — | — |
| Q4 2023 Nov 8, 2023 | $42.53M | $55.43M | +30.33% | -$3.60 | -$3.60 | +0.00% | — | — |
| Q3 2023 Aug 9, 2023 | $52.19M | $80.57M | +54.37% | -$3.60 | -$3.60 | +0.00% | — | — |
| Q2 2023 May 10, 2023 | $71.58M | $80.70M | +12.74% | -$3.60 | -$3.20 | +11.11% | — | — |
| Q1 2023 Mar 1, 2023 | $71.68M | $98.28M | +37.12% | -$12.00 | -$1.60 | +86.67% | — | — |
| Q4 2022 Nov 14, 2022 | $60.35M | $66.40M | +10.02% | -$10.00 | -$16.00 | -60.00% | — | — |
| Q3 2022 Aug 15, 2022 | $78.83M | $144.62M | +83.45% | -$2.00 | -$16.40 | -720.00% | — | — |
| Q2 2022 May 16, 2022 | $105.67M | $168.41M | +59.38% | -$1.60 | -$2.00 | -25.00% | — | — |
| Q1 2022 Mar 28, 2022 | $94.81M | $148.49M | +56.62% | -$2.00 | -$0.40 | +80.00% | — | — |
| Q4 2021 Nov 15, 2021 | $55.20M | $77.61M | +40.60% | -$1.60 | -$2.80 | -75.00% | — | — |
| Q3 2021 Sep 20, 2021 | — | $43.64M | — | — | -$1.67 | — | — | — |
| Q2 2021 May 24, 2021 | — | $44.10M | — | — | -$2.28 | — | — | — |